Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1997 1
1999 2
2000 1
2009 2
2010 2
2011 3
2012 4
2013 7
2014 7
2015 11
2016 12
2017 6
2018 7
2019 8
2020 5
2021 4
2022 12
2023 7
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Nacev BA, Bradic M, Woo HJ, Richards AL, Kelly CM, Dickson MA, Gounder MM, Keohan ML, Chi P, Movva S, Maki RG, Slotkin EK, Rosenbaum E, Avutu V, Chan JE, Banks LB, Adamson T, Singer S, Antonescu CR, Tap WD, Donoghue MT, D'Angelo SP. Nacev BA, et al. Among authors: dickson ma. J Immunother Cancer. 2025 Sep 5;13(9):e012357. doi: 10.1136/jitc-2025-012357. J Immunother Cancer. 2025. PMID: 40912740 Free PMC article.
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma.
Rosenbaum E, Seier K, Bradic M, Movva S, Kelly CM, Dickson MA, Keohan ML, Gounder MM, Chi P, Nacev BA, Chan JE, Avutu V, Biniakewitz M, Jasnani S, Duchemin M, Desir R, Wong P, Erinjeri J, Hwang S, Antonescu CR, Qin LX, Tap WD, D'Angelo SP. Rosenbaum E, et al. Among authors: dickson ma. ESMO Open. 2025 Aug;10(8):105522. doi: 10.1016/j.esmoop.2025.105522. Epub 2025 Jul 25. ESMO Open. 2025. PMID: 40714516 Free PMC article. Clinical Trial.
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.
Kelly CM, Bradic M, Saunds S, Avutu V, Banks L, Chan J, D'Angelo SP, Dickson MA, Gounder MM, Keohan ML, Maki RG, Movva S, Rosenbaum E, Bartlett EK, Crago AM, Untch BR, Strong V, Singer S, Hwang S, Antonescu CR, Sivaprakasam K, Lapshina M, Hasan M, Shah R, Berger MF, Qin LX, Tap WD, Chi P. Kelly CM, et al. Among authors: dickson ma. Clin Cancer Res. 2025 Oct 1;31(19):4110-4121. doi: 10.1158/1078-0432.CCR-25-0145. Clin Cancer Res. 2025. PMID: 40694085 Clinical Trial.
Clinical applications of and molecular insights from RNA sequencing in a rare disease cohort.
Stark JC, Pipko N, Liang Y, Szuto A, Tsoi CT, Dickson MA, Yuki KE, Hou H, Scholten S, Pulsifer K, Acker M, Laver M, Murthy H, Moran OM, Bonnell E, Liang N, Sidhu J, Dupuis L, Seno MMG; Care4Rare Canada Consortium; Chard M, Jobling RK, Cameron J, Chami R, Inbar-Feigenberg M, Wilson MD, Chitayat DA, Boycott KM, Kyriakopoulou L, Mendoza-Londono R, Marshall CR, Dowling JJ, Costain G, Deshwar AR. Stark JC, et al. Among authors: dickson ma. Genome Med. 2025 Jul 1;17(1):72. doi: 10.1186/s13073-025-01494-w. Genome Med. 2025. PMID: 40597352 Free PMC article.
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma.
Movva S, Seier K, Bradic M, Charalambous K, Rosenbaum E, Kelly CM, Cohen SM, Hensley ML, Avutu V, Banks LB, Chan JE, Chi P, D'Angelo S, Dickson MA, Gounder MM, Keohan ML, Maki RG, Green A, Makker V, Rubinstein MM, Saunds S, Cho JM, Lefkowitz RA, Erinjeri J, Qin LX, Shah R, Wong P, Tap W. Movva S, et al. Among authors: dickson ma. J Immunother Cancer. 2025 Jun 12;13(6):e012020. doi: 10.1136/jitc-2025-012020. J Immunother Cancer. 2025. PMID: 40514070 Free PMC article. Clinical Trial.
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial.
Mowery YM, Ballman KV, Hong AM, Schuetze SM, Wagner AJ, Monga V, Heise RS, Attia S, Choy E, Burgess MA, Bae S, Pryor DI, Van Tine BA, Tinoco G, Chmielowski B, Freeman C, Gronchi A, Meyer CF, Dickson MA, Hartner L, Davis LE, Powers BC, Moding EJ, Weinhold KJ, van de Rijn M, Brigman BE, Riedel RF, Kirsch DG. Mowery YM, et al. Among authors: dickson ma. Lancet. 2024 Nov 23;404(10467):2053-2064. doi: 10.1016/S0140-6736(24)01812-9. Epub 2024 Nov 12. Lancet. 2024. PMID: 39547252 Clinical Trial.
Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C.
O'Hara MH, Jegede O, Dickson MA, DeMichele AM, Piekarz R, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Onitilo A, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. O'Hara MH, et al. Among authors: dickson ma. Clin Cancer Res. 2025 Jan 6;31(1):56-64. doi: 10.1158/1078-0432.CCR-24-0036. Clin Cancer Res. 2025. PMID: 39437014 Free PMC article. Clinical Trial.
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Movva S, Seier K, Avutu V, Banks LB, Chan J, Chi P, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Maki R, Rosenbaum E, Salcito T, Rodriguez K, Dempsey R, Meyers PA, Cohen SM, Hensley ML, Konner JA, Schram AM, Lefkowitz RA, Erinjeri JP, Qin LX, Tap WD, D'Angelo SP. Movva S, et al. Among authors: dickson ma. Clin Cancer Res. 2024 Dec 16;30(24):5612-5619. doi: 10.1158/1078-0432.CCR-24-2519. Clin Cancer Res. 2024. PMID: 39405335 Free PMC article.
100 results